Krilogy Financial’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Krilogy Financial’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-475	Closed	-$82K	–	764
2018 Q3	$82K	Buy	+475	New	+$68.5K	0.02%	248
2018 Q2	–	Sell	-425	Closed	-$48K	–	696
2018 Q1	$48K	Hold	425	–	–	0.01%	336
2017 Q4	$56K	Sell	425 -400	-48%	-$47K	0.01%	306
2017 Q3	$84K	Sell	825 -100	-11%	-$10.7K	0.02%	275
2017 Q2	$93K	Buy	925 +775	+517%	+$83.4K	0.03%	225
2017 Q1	$17K	Hold	150	–	–	0.01%	445
2016 Q4	$17K	Buy	+150	New	+$18.1K	0.01%	445
2016 Q3	–	Sell	-900	Closed	-$82K	–	789
2016 Q2	$82K	Hold	900	–	–	0.03%	228
2016 Q1	$65K	Hold	900	–	–	0.03%	230
2015 Q4	$62K	Buy	+900	New	+$73.3K	0.06%	116

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Krilogy Financial's GWPH Position: Q4 2018 in Review

Krilogy Financial sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2018, closing a stake of 475 shares — an estimated $82K sold.

Krilogy Financial first reported a position in GWPH in Q4 2015 and held it in 10 quarters. The position peaked at $93K in Q2 2017. 277 funds tracked by Wall St. Rank hold GWPH as of Q4 2018.

Krilogy Financial reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2018 after selling out during the quarter.
Krilogy Financial sold 475 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2018, an estimated $82K.
Krilogy Financial first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2015 and held it in 10 quarters.
Krilogy Financial's GW Pharmaceuticals Plc American Depositary Shares position peaked at $93K in Q2 2017.
277 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2018.

Based on Krilogy Financial's 13F filing for Q4 2018, filed 14 Feb 2019.